Fifty five women with progressive metastatic breast cancer who were paramenopausal 1 to less than 5 years since last menstrual period or castrated were randomized to receive either megestrol acetate 150 mg m2 daily in three divided doses or tamoxifen 10 mg twice daily <a href=https://fastpriligy.top/>priligy india</a>